GAMMADELTA THERAPEUTICS

gammadelta-therapeutics-logo

GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.

#SimilarOrganizations #People #Financial #Website #More

GAMMADELTA THERAPEUTICS

Industry:
Biotechnology Health Care Health Diagnostics Therapeutics

Founded:
2016-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.gammadeltatx.com

Total Employee:
51+

Status:
Closed

Contact:
+44 (0207) 6911122

Email Addresses:
[email protected]

Total Funding:
100 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Person Schema Gravatar Profiles Amazon Route 53 DMARC AWS Global Accelerator


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

carbylan-therapeutics-logo

Carbylan Therapeutics

Carbylan Therapeutics was founded in 2004

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

ieso-logo

ieso

Transforming mental healthcare by unlocking the power of clinical data

imutex-logo

Imutex

Imutex, a startup with a Phase IIa-ready universal flu vaccine.

mavalon-therapeutics-logo

Mavalon Therapeutics

Mavalon is developing drugs to stop the progression of Parkinson's disease.

my-personal-therapeutics-vivan-therapeutics-logo

My Personal Therapeutics/ VIVAN Therapeutics

My Personal Therapeutics (MPT) is a company pioneering personalized cancer therapeutics using a new assay technology.

orbus-therapeutics-logo

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

stemsight-logo

StemSight

StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

stromal-therapeutics-logo

Stromal Therapeutics

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

treos-bio-logo

Treos Bio

Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.


Current Advisors List

adrian-hayday_image

Adrian Hayday Board Member @ GammaDelta Therapeutics
Board_member

Current Employees Featured

sandra-van-wetering_image

Sandra Van Wetering
Sandra Van Wetering VP Process Science and Manufacturing @ GammaDelta Therapeutics
VP Process Science and Manufacturing
2020-08-01

adrian-hayday_image

Adrian Hayday
Adrian Hayday Co-Founder @ GammaDelta Therapeutics
Co-Founder

Founder


adrian-hayday_image

Adrian Hayday

Acquisitions List

Date Company Article Price
2018-05-31 Lymphact Lymphact acquired by GammaDelta Therapeutics N/A

Investors List

abingworth-management_image

Abingworth

Abingworth investment in Venture Round - GammaDelta Therapeutics

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Venture Round - GammaDelta Therapeutics

cancer-research-technology_image

Cancer Research Horizons

Cancer Research Horizons investment in Seed Round - GammaDelta Therapeutics

kings-college-london_image

King's College London

King's College London investment in Seed Round - GammaDelta Therapeutics

the-francis-crick-institute_image

The Francis Crick Institute

The Francis Crick Institute investment in Seed Round - GammaDelta Therapeutics

abingworth-management_image

Abingworth

Abingworth investment in Seed Round - GammaDelta Therapeutics

Official Site Inspections

http://www.gammadeltatx.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.33 K

  • Host name: afe41c95a9e82f02c.awsglobalaccelerator.com
  • IP address: 13.248.133.121
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "GammaDelta Therapeutics" on Search Engine